Abvemy 100mg

Abvemy 100 (Bevacizumab) is a medication used to treat various types of cancer, including:

• Colorectal cancer
• Breast cancer
• Non-small cell lung cancer (NSCLC)
• Kidney cancer (renal cell carcinoma)
• Ovarian cancer

Composition:

Bevacizumab is a monoclonal antibody that binds to vascular endothelial growth factor A (VEGFA), a protein that helps form new blood vessels. By blocking the action of VEGFA, Bevacizumab inhibits the growth of new blood vessels and reduces the blood supply to tumors.

Indications:

Abvemy 100 (Bevacizumab) is indicated for the treatment of:

• Metastatic colorectal cancer in combination with fluorouracil-based chemotherapy
• Metastatic breast cancer in combination with chemotherapy
• Advanced non-small cell lung cancer (NSCLC) in combination with chemotherapy
• Metastatic kidney cancer (renal cell carcinoma)
• Recurrent or persistent ovarian cancer

Dosage:

The recommended dosage of Abvemy 100 is:

• 100 mg administered as an intravenous infusion every 2 weeks

Side Effects:

Common side effects of Abvemy 100 include:

• Headache
• High blood pressure
• Nausea
• Vomiting
• Fatigue
• Diarrhea
• Stomatitis (mouth sores)
• Proteinuria (excess protein in urine)
• Hematuria (blood in urine)
• Epistaxis (nosebleed)

Contraindications:

Abvemy 100 is contraindicated in patients who have:

• A history of severe allergic reactions to the medication
• A history of hemorrhage or bleeding disorders
• Uncontrolled hypertension
• Severe kidney disease or kidney failure
• Severe liver disease or liver failure

Important Note:

Abvemy 100 is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Patients should be advised to monitor their blood pressure and blood counts regularly during treatment.